|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.490 CNY | -3.23% |
|
+1.81% | -18.81% |
| 25/05 | North China Pharma Gets China Nod for Kidney Anemia Drug | MT |
| 24/04 | North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 770.36Cr 113.37Cr 99Cr 91Cr 85Cr 160.88Cr 11TCr 163.47Cr 1.1TCr 426.36Cr 5.31TCr 425.63Cr 416.42Cr 18TCr | P/E 2024 |
69.9x | P/E 2025 | 51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1.74TCr 255.74Cr 223.8Cr 206.25Cr 191.17Cr 362.9Cr 24TCr 368.75Cr 2.47TCr 961.76Cr 12TCr 960.12Cr 939.33Cr 41TCr | EV / Sales 2024 |
1.89x | EV / Sales 2025 | 2.07x |
| Free-Float |
40.58% | Yield 2024 |
0.58% | Yield 2025 | 0.63% |
| 1 day | -3.23% | ||
| 1 week | +1.81% | ||
| Current month | +5.15% | ||
| 1 month | +1.35% | ||
| 3 months | -18.51% | ||
| 6 months | -20.11% | ||
| Current year | -18.81% |
| 1 week | 4.21 |  | 4.68 |
| 1 month | 4.11 | | 4.68 |
| Current year | 4.11 | | 6.07 |
| 1 year | 4.11 | | 7.46 |
| 3 years | 3.83 | | 7.46 |
| 5 years | 3.83 | | 13.45 |
| 10 years | 3.83 | | 20.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Zhang
CEO | Chief Executive Officer | 55 | 28/11/2025 |
Zhi Guang Xiao
DFI | Director of Finance/CFO | 46 | 10/04/2024 |
Jing Yang
IRC | Investor Relations Contact | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yao Cao
CHM | Chairman | 49 | 22/03/2016 |
Ji Gang Xie
BRD | Director/Board Member | 53 | 23/04/2021 |
Ya Lou Wang
BRD | Director/Board Member | 54 | 12/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/25/25 | Buy | Chairman | 1,600 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.23% | +1.81% | -30.39% | -19.53% | 113.37Cr | |
| +2.96% | +3.01% | +59.87% | +173.31% | 1,10200Cr | |
| +3.05% | +5.23% | +72.11% | +67.81% | 64TCr | |
| -0.04% | +1.20% | +35.72% | +87.93% | 45TCr | |
| +0.33% | -2.07% | +27.62% | +22.57% | 34TCr | |
| -0.81% | +0.17% | +29.90% | +49.33% | 29TCr | |
| -1.24% | +4.08% | -25.78% | -39.02% | 22TCr | |
| +0.45% | +1.65% | +25.65% | +68.35% | 20TCr | |
| +5.21% | +7.93% | +21.99% | +83.23% | 17TCr | |
| +1.48% | -0.04% | -4.64% | -32.25% | 14TCr | |
| Average | +0.22% | +1.87% | +21.21% | +46.17% | 35.46TCr | |
| Weighted average by Cap. | +1.42% | +1.86% | +41.94% | +87.55% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 986.96Cr 145.25Cr 127.11Cr 117.14Cr 108.58Cr 206.11Cr 14TCr 209.43Cr 1.4TCr 546.23Cr 6.8TCr 545.3Cr 533.49Cr 24TCr | 924.17Cr 136.01Cr 119.02Cr 109.69Cr 101.67Cr 193Cr 13TCr 196.11Cr 1.32TCr 511.48Cr 6.37TCr 510.61Cr 499.55Cr 22TCr |
| Net income | 13Cr 1.87Cr 1.64Cr 1.51Cr 1.4Cr 2.65Cr 177.38Cr 2.69Cr 18Cr 7.03Cr 88Cr 7.02Cr 6.86Cr 302.57Cr | 18Cr 2.69Cr 2.36Cr 2.17Cr 2.01Cr 3.82Cr 255.68Cr 3.88Cr 26Cr 10Cr 126.19Cr 10Cr 9.9Cr 436.15Cr |
| Net Debt | 978.97Cr 144.07Cr 126.08Cr 116.19Cr 107.7Cr 204.44Cr 14TCr 207.74Cr 1.39TCr 541.81Cr 6.75TCr 540.89Cr 529.18Cr 23TCr | 967.38Cr 142.37Cr 124.59Cr 114.82Cr 106.42Cr 202.02Cr 14TCr 205.28Cr 1.38TCr 535.4Cr 6.67TCr 534.49Cr 522.91Cr 23TCr |
Employees
9,972
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | CN¥4.490 | -3.23% | 1,88,67,111 |
| 06/26/06 | CN¥4.640 | +1.09% | 2,32,58,930 |
| 03/26/03 | CN¥4.590 | +1.77% | 2,04,42,246 |
| 02/26/02 | CN¥4.510 | +1.12% | 2,27,98,307 |
| 01/26/01 | CN¥4.460 | +4.45% | 2,47,61,326 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600812 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
